Kristy Shield-Artin

3PUBLICATIONS
30CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 08, 2026
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial.

|Nov 05, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound

|Oct 26, 2021
Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

Zikou Liu, Laura F Dagley, Kristy Shield-Artin

Pageof 1

Frequent Collaborators

2 joint publications

Matthew J Wakefield

2 joint publications

Cassandra J Vandenberg

2 joint publications

Sally Baron-Hay

2 joint publications

U G Imalki U Kariyawasam